[
    [
        {
            "time": "",
            "original_text": "华森制药：购买的人福医药的产品因疫情原因，场地验证以及技术转移有所推迟，目前正在进行积极推进相关工作",
            "features": {
                "keywords": [
                    "华森制药",
                    "人福医药",
                    "疫情",
                    "场地验证",
                    "技术转移",
                    "推迟",
                    "积极推进"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华森制药：购买的人福医药的产品因疫情原因，场地验证以及技术转移有所推迟，目前正在进行积极推进相关工作",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]